封面
市場調查報告書
商品編碼
1518496

藥筒市場- 按組件(柱塞、小瓶[玻璃、塑膠]、密封件)、類型(雙室、大容量)、容量、使用設備(筆式注射器、自動注射器、穿戴式注射器)、應用、最終用戶- 全球2024 - 2032 年預測

Pharmaceutical Cartridges Market - By Component (Plungers, Vials [Glass, Plastic], Seals), Type (Dual Chamber, Large-volume), Capacity, Usage Device (Pen Injectors, Autoinjectors, Wearable Injectors), Application, End-user - Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於全球藥品生產的成長以及對積極支持高效藥物輸送和包裝解決方案的強烈需求,預計 2024 年至 2032 年藥品藥筒市場規模的複合年成長率將達到 7.3%。隨著藥品生產的不斷擴大,藥筒被用來確保準確的劑量和無菌包裝。

工程師和製造商正在關注材料和設計的進步,以滿足製藥行業不斷變化的需求。這種成長正在提高藥物輸送系統的可靠性和效率,從而改善全球醫療保健結果。例如,2022年5月,肖特宣布投資數百萬歐元用於即用型藥筒生產,標誌著醫藥藥筒的新時代。此措施有助於增強製造能力並滿足對先進藥物輸送解決方案不斷成長的需求。

整個市場分為組件、類型、使用設備、容量、應用程式、最終用戶和區域。

就組件而言,密封件領域的藥筒市場預計從2024 年到2032 年將錄得顯著的複合年成長率。性。製造商正在開發先進的密封技術以提高性能和可靠性。材料和設計方面不斷湧現的創新也確保了與各種藥物配方的兼容性,以維持藥物在整個保存期限內的功效和安全性。

從應用來看,由於對提供精確可靠的藥物輸送系統的強烈需求,心臟病學領域的藥筒產業預計將在 2024 年至 2032 年期間成長。這些藥筒增強了心臟病藥物的管理,同時確保劑量一致並降低人為錯誤的風險。研究人員和醫療專業人員也在探索將這些墨盒整合到創新治療方案中的新方法,以改善患者的治療效果並簡化心血管疾病的管理。

從區域來看,在病患安全和便利的推動下,亞太地區藥用藥筒市場規模預計將在 2024 年至 2032 年間呈現強勁成長,這將推動新興市場的持續擴張。製造商正在開發可確保精確劑量和易於管理的藥筒,以增強該地區的整體患者護理。隨後,對改進的藥筒設計和材料的需求不斷成長,以支持更安全、更有效的治療,同時透過方便用戶使用的功能促進患者的依從性和舒適度,這將推動區域產品需求。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 對易於使用和方便的藥品包裝解決方案的需求不斷成長
      • 藥物傳輸和製造技術不斷進步
      • 越來越關注生物製劑和個人化醫療的趨勢
    • 產業陷阱與挑戰
      • 製造複雜性
      • 嚴格的監管框架
  • 成長潛力分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按組成部分,2021 - 2032 年

  • 主要趨勢
  • 柱塞
    • 氯化丁基橡膠
    • 溴化丁基橡膠
  • 小瓶
    • 玻璃
      • 類型1
      • 2型
      • 3型
    • 塑膠
      • 聚丙烯(PP)
      • 環烯烴共聚物(COC)
      • 環烯烴聚合物(COP)
      • 聚乙烯
      • 其他塑膠瓶
  • 密封件

第 6 章:市場估計與預測:按類型,2021 - 2032

  • 主要趨勢
  • 雙室墨盒
  • 大容量墨盒

第 7 章:市場估計與預測:按產能分類,2021 - 2032 年

  • 主要趨勢
  • 0.5毫升
  • 1.8毫升
  • 2毫升至2.5毫升
  • 3毫升
  • 5毫升
  • 10毫升以上

第 8 章:市場估計與預測:按使用設備分類,2021 - 2032 年

  • 主要趨勢
  • 筆式注射器
  • 自動注射器
  • 穿戴式注射器
  • 其他使用設備

第 9 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 牙齒保健
  • 糖尿病護理
  • 神經病學
  • 心臟病學
  • 腫瘤學
  • 其他應用

第 10 章:市場估計與預測:按最終用戶分類,2021 年 - 2032 年

  • 主要趨勢
  • 醫院
  • 專科診所
  • 門診手術中心
  • 家庭護理設置
  • 其他最終用戶

第 11 章:市場估計與預測:按地區,2021 - 2032

  • 主要動向:按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 12 章:公司簡介

  • AptarGroup, Inc.
  • Baxter International Inc.
  • Dätwyler Holding Inc.
  • Gerresheimer AG
  • Merck KGaA
  • Nipro Corporation
  • Schott Group
  • Shandong Medicinal Glass Co., Ltd.
  • Stevanato Group
  • Transcoject GmbH
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
簡介目錄
Product Code: 9223

Pharmaceutical Cartridges Market size is projected to record 7.3% CAGR from 2024 to 2032, due to the rise in pharmaceutical production worldwide along with the strong need for actively supporting efficient drug delivery and packaging solutions. With the expanding pharmaceutical production, cartridges are used for ensuring accurate dosing and sterile packaging.

Engineers and manufacturers are focusing on advancements in materials and designs to meet the evolving needs of the pharmaceutical industry. This growth is enhancing reliability and efficiency in drug delivery systems for improved healthcare outcomes globally. For instance, in May 2022, SCHOTT announced a double-digit million Euro investment in ready-to-use cartridge production for marking a new era in pharmaceutical cartridges. This initiative helped in enhancing manufacturing capabilities and meeting the growing demand for advanced drug delivery solutions.

The overall market is segregated into component, type, usage device, capacity, application, end-user, and region.

In terms of component, the pharmaceutical cartridges market from the seals segment is expected to record significant CAGR from 2024 to 2032. Seals for pharmaceutical cartridges are used for ensuring the integrity and sterility of medications by preventing contamination and leakage. Manufacturers are developing advanced sealing technologies to enhance performance and reliability. Rising innovations in materials and designs are also ensuring compatibility with various drug formulations for maintaining the efficacy and safety of medications throughout their shelf life.

By application, the pharmaceutical cartridges industry from the cardiology segment is projected to rise from 2024 to 2032 owing to the strong need for providing precise and reliable drug delivery systems. These cartridges are enhancing the administration of medications for heart conditions whilst ensuring consistent dosages and reducing the risk of human errors. Researchers and medical professionals are also exploring new ways to integrate these cartridges into innovative treatment protocols to improve patient outcomes and streamline the management of cardiovascular diseases.

Regionally, the Asia Pacific pharmaceutical cartridges market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing expansion into emerging markets, driven by patient safety and convenience. Manufacturers are developing cartridges that ensure precise dosing and easy administration for enhancing overall patient care in the region. Subsequently, the growing need for improved cartridge designs and materials for supporting safer, more effective treatments whilst facilitating patient compliance and comfort with user-friendly features will drive the regional product demand.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for easy-to-use and convenient pharmaceutical packaging solutions
      • 3.2.1.2 Growing advances in pharmaceutical drug delivery and manufacturing technology
      • 3.2.1.3 Increasing focus on biologics and the trend towards personalized medicine
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Manufacturing complexity
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Million)

  • 5.1 Key trends
  • 5.2 Plungers
    • 5.2.1 Chlorinated butyl rubber
    • 5.2.2 Bromobutyl rubber
  • 5.3 Vials
    • 5.3.1 Glass
      • 5.3.1.1 Type 1
      • 5.3.1.2 Type 2
      • 5.3.1.3 Type 3
    • 5.3.2 Plastic
      • 5.3.2.1 Polypropylene (PP)
      • 5.3.2.2 Cyclic olefin copolymer (COC)
      • 5.3.2.3 Cyclic olefin polymer (COP)
      • 5.3.2.4 Polyethylene
      • 5.3.2.5 Other plastic vials
  • 5.4 Seals

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Million)

  • 6.1 Key trends
  • 6.2 Dual chamber cartridges
  • 6.3 Large-volume cartridges

Chapter 7 Market Estimates and Forecast, By Capacity, 2021 - 2032 ($ Million)

  • 7.1 Key trends
  • 7.2 0.5 ml
  • 7.3 1.8 ml
  • 7.4 2ml to 2.5 ml
  • 7.5 3 ml
  • 7.6 5 ml
  • 7.7 More than 10 ml

Chapter 8 Market Estimates and Forecast, By Usage Device, 2021 - 2032 ($ Million)

  • 8.1 Key trends
  • 8.2 Pen injectors
  • 8.3 Autoinjectors
  • 8.4 Wearable injectors
  • 8.5 Other usage devices

Chapter 9 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)

  • 9.1 Key trends
  • 9.2 Dental care
  • 9.3 Diabetes care
  • 9.4 Neurology
  • 9.5 Cardiology
  • 9.6 Oncology
  • 9.7 Other applications

Chapter 10 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Million)

  • 10.1 Key trends
  • 10.2 Hospitals
  • 10.3 Specialty clinics
  • 10.4 Ambulatory surgical centers
  • 10.5 Homecare settings
  • 10.6 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 AptarGroup, Inc.
  • 12.2 Baxter International Inc.
  • 12.3 Dätwyler Holding Inc.
  • 12.4 Gerresheimer AG
  • 12.5 Merck KGaA
  • 12.6 Nipro Corporation
  • 12.7 Schott Group
  • 12.8 Shandong Medicinal Glass Co., Ltd.
  • 12.9 Stevanato Group
  • 12.10 Transcoject GmbH
  • 12.11 West Pharmaceutical Services, Inc.
  • 12.12 Ypsomed AG